MétaCan
Menu
← Back to cohort
Record W2800955910 · doi:10.1136/bmj.k2133

Trump promises to reduce drug prices but drops campaign promises

2018· article· en· W2800955910 on OpenAlexaboutno aff
Janice Hopkins Tanne

Bibliographic record

VenueBMJ · 2018
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicPharmaceutical Economics and Policy
Canadian institutionsnot available
Fundersnot available
KeywordsData scienceComputer scienceDrugDrug pricesWorld Wide WebMedicinePharmacologyEconomicsPublic economics

Abstract

fetched live from OpenAlex

President Donald Trump has outlined measures to reduce the prices US consumers pay for prescription drugs through a program called American Patients First,1 but he did not follow through on two campaign promises. During his campaign Trump had promised to allow the government to negotiate drug prices for the Medicare insurance program, which provides drugs for about 60 million older people, and to allow US consumers to import drugs from Canada. Stock prices of drug and healthcare companies immediately rose after the new announcement.2 The United States had the world’s highest per capita spending on pharmaceutical drugs in 2015 …

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.078
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.058
Threshold uncertainty score0.194

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.078
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0040.005
Scholarly communication0.0110.010
Open science0.0010.004
Research integrity0.0120.020
Insufficient payload (model declined to judge)0.0580.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.075
GPT teacher head0.331
Teacher spread0.256 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueBMJ→Same topicPharmaceutical Economics and Policy→French-language works237,207→